Report: FDA underfunded, understaffed

An FDA advisory committee has joined the chorus lamenting an underfunded, understaffed regulatory agency. Released Friday, the report not only castigates the FDA for its woeful understanding of current science, but said its staffing is inadequate for the job and its IT systems are obsolete, and therefore completely ineffective.

Believe it or not, FDA inspectors hand-write their reports. Other dangerous-product reports aren't analyzed or compared fast enough. And the agency doesn't have backup systems, so data gets lost in system crashes.

What would fix the problem? Doubling the agency's budget, for starters. Consumers pay 1.5 cents per day to operate the FDA, the report states, and 3 cents a day wouldn't be too much to ask.

- see this release on the findings
- read the report from USA Today

Related Articles:
FDA badly needs more money, staff. Report
The FDA: Caught between a rock and a hard place. Report
FDA can't guarantee drug safety. Report
Overseas drugmaking goes unsupervised. Report
Poll finds problems at the FDA. Report

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.